Elite in Glaucoma

Christophe Baudouin

Versailles St Quentin, 
Paris, FR 
Elite in Glaucoma
Versailles St Quentin, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Christophe Baudouin practices in Paris, France. Mr. Baudouin is rated as an Elite expert by MediFind in the treatment of Glaucoma. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Dry Eye Syndrome, Trabeculectomy, and Cataract Removal.

His clinical research consists of co-authoring 386 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 121 articles and participated in 1 clinical trial in the study of Glaucoma.

Gender
Male

Locations

Versailles St Quentin, Paris, France
Other Locations
28 Rue De, Charenton-le-pont, 75012, France
Versailles, France
Boulogne-billancourt, 92100, France
Gif-sur-yvette, 91190, France
Saclay, France
Université Versailles St Quentin En Yvelines, Montigny-sur-loing, 78180, France
Reims, France
Innovation R&D Direction, Epernon, France
Saint-quentin-le-verger, France
Raray, France
6, Avenue De L'Île De France, Pontoise, 95300, France
U968, St Quentin En Yvelines, Sete, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of Wharton's Jelly Extract Eye Drops, Treated by the AMTRIX Process, in the Treatment of Chronic Keratitis
Evaluation of Wharton's Jelly Extract Eye Drops, Treated by the AMTRIX Process, in the Treatment of Chronic Keratitis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Biological
Study Drug: SygeLIX-Coll-T
Study Phase: Phase 1
Comparison of the Performance and Safety of T2259 Versus Vismed Multi in Dry Eye Patients With Superficial Keratitis.
Comparison of the Performance and Safety of T2259 Versus Vismed Multi in Dry Eye Patients With Superficial Keratitis.
Enrollment Status: Completed
Publish Date: November 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01% and Lumigan® 0.03% Unit Dose, in Patients With Primary Open Angle Glaucoma or Ocular Hypertension, Stabilized by Lumigan® 0.01% With Ocular Surface Intolerance
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01% and Lumigan® 0.03% Unit Dose, in Patients With Primary Open Angle Glaucoma or Ocular Hypertension, Stabilized by Lumigan® 0.01% With Ocular Surface Intolerance
Enrollment Status: Completed
Publish Date: April 02, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

386 Total Publications

Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.
Journal: Allergy
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Baudouin's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile